Mark Nance
General Counsel chez ENVISTA HOLDINGS CORPORATION
Fortune : 636 696 $ au 31/03/2024
Profil
Mark E.
Nance is currently the Secretary, Senior Vice President & General Counsel at Envista Holdings Corp.
He previously worked as the General Counsel at GE Aerospace, Vice President-Corporate Development at Integrated Nano-Technologies LLC, Senior Vice President & Global General Counsel at Mylan NV, Senior Vice President & Global General Counsel at GE UK Group, and Senior Vice President & Global General Counsel at GE Healthcare Medical Diagnostics.
He also served as the Chief Legal Officer & General Counsel at INSYS Therapeutics, Inc. from 2018 to 2019.
Mr. Nance obtained his undergraduate degree from the University of Missouri and his graduate degree from Cornell Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENVISTA HOLDINGS CORP.
0,02% | 25/03/2024 | 29 780 ( 0,02% ) | 636 696 $ | 31/03/2024 |
Postes actifs de Mark Nance
| Sociétés | Poste | Début |
|---|---|---|
| ENVISTA HOLDINGS CORPORATION | General Counsel | 01/09/2019 |
Anciens postes connus de Mark Nance
| Sociétés | Poste | Fin |
|---|---|---|
| INSYS THERAPEUTICS, INC. | General Counsel | 31/07/2019 |
Mylan NV
 Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | General Counsel | 01/05/2017 |
GE UK Group
 GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding private company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | General Counsel | - |
| GE Healthcare Medical Diagnostics | General Counsel | - |
| Integrated Nano-Technologies LLC | Corporate Officer/Principal | - |
Formation de Mark Nance
| University of Missouri | Undergraduate Degree |
| Cornell Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GE AEROSPACE | Producer Manufacturing |
| ENVISTA HOLDINGS CORPORATION | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Integrated Nano-Technologies LLC | Health Technology |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
GE UK Group
GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding private company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous |
| GE Healthcare Medical Diagnostics | |
INSYS Therapeutics, Inc.
 INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
